Profile Picture
Rewards
  • Search
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
    • Real Estate
    • My Bing
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Kiss performs final concert
Divorce after 14 years
UK police arrest protesters
Joins Five-Timers Club
Apologizes for comments
Celebrates 42nd birthday
‘I am deeply human’
'Wasn't it obvious?'
$1.5M to salvage jet plane
Williams leaving CO staff?
PH university blast: 4 dead
Oldest gun factory to close
Pulls negotiators from Qatar
Peru mine attack: 9 killed
Super PAC names 3rd CEO
Expected to play vs. Bengals
Elected to Hall of Fame
Belarus pres to visit China
Pakistan shooting kills 9
Osprey crash yields no clues
Registers career-best win
Dodgers to re-sign Kelly?
Fortnite and Lego join forces
Bruins beat Leafs in OT
Honored with a Barbie doll
Thunder beat Mavericks
Kyiv accuses Russian forces
'Halo' season 2 trailer
Michigan wins Big Ten title
Paris attack: 1 killed, 2 hurt
Harris calls for restraint
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
3,890 results
hrexecutive
2d
As anti-obesity drug prices soar, how employers can navigate difficult choices
High prices for anti-obesity drugs known as GLP-1 medications, coupled with high employee demand, are giving employers a lot ...
Reuters2d
Maker of Wegovy, Ozempic showers money on U.S. obesity doctors
Dr. Lee Kaplan took the stage with an urgent message, telling fellow physicians they have a powerful weapon to fight the ...
The Messenger on MSN1d
Pfizer Suffers Setback in Weight Loss Trial After Patients Drop Pill Due to Uncomfortable Side Effects
While Wegovy, Ozempic and Zepbound soar, other weight loss medications are struggling.
4don MSN
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real-world study says
Patients on Eli Lilly's Mounjaro were more likely to lose weight and experienced larger reductions in body weight compared to ...
3mon
Wegovy weight-loss drugmaker sees profits soar
The maker of weight-loss jabs Wegovy and Ozempic, Danish pharmaceutical giant Novo Nordisk, has reported a sharp rise in ...
The Motley Fool1mon
Ozempic Sales Soar 56% in Q3. But Is Eli Lilly a Better Stock to Buy Than Novo Nordisk?
Novo Nordisk delivered sizzling Q3 growth, thanks mainly to soaring sales for Ozempic. However, Eli Lilly's Q3 results looked even better than Novo Nordisk's. Both stocks could be winners for ...
Futurism2mon
Snack Food CEO Vows to Battle Ozempic
As the popularity of appetite-suppressing drugs like Ozempic and Wegovy continues to skyrocket, one of America's chief snack food overlords is readying himself — and his company's delicious ...
Healthline18d
Black People Are Facing Greater Challenges Accessing Anti-Obesity Drugs Like Ozempic and Wegovy
Share on Pinterest Diabetes and obesity disproportionately impact Black people, yet they are facing greater challenges gaining access to GLP-1 medications like Ozempic that could help treat these ...
Medindia17d
Medications and their Potential to Cause Increase 'Throat sore'
This section presents medications that are known to potentially lead to 'Throat sore' as a side effect." It's important to note that mild side effects are quite common with medications. Please be ...
The Guardian1mon
Sales soar at Danish firm behind weight-loss drug semaglutide
Novo Nordisk says it struggling to keep up with demand after becoming Europe’s most valuable company The maker of blockbuster weight-loss drug semaglutide has reported a steep rise in sales and ...
Hosted on MSN1mon
Ozempic Sales Soar 56% in Q3. But Is Eli Lilly a Better Stock to Buy Than Novo Nordisk?
Is the fervor over Ozempic just a passing fad? It doesn't appear to be the case after Novo Nordisk (NYSE: NVO) announced its results for the first nine months of 2023 on Thursday morning.
BBC3mon
Wegovy weight-loss drugmaker sees profits soar
The maker of weight-loss jabs Wegovy and Ozempic, Danish pharmaceutical giant Novo Nordisk, has reported a sharp rise in profits on the back of surging demand for the drugs. Net profits were 39 ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Get the Bing App
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices